Mariana Marques, MD @MCMarquesMD X Profile

Mariana Marques, MD

@MCMarquesMD

Followers

792

Following

3K

Media

84

Statuses

856

Pediatric Rheumatologist@ NIH/Autoinflammation /sJIA/genomics/ immune dysregulation. Opinions =my own

Joined September 2019

Don't wanna be here? Send us removal request.

Mariana Marques, MD

@MCMarquesMD

2 years

I’m so thankful to my mentors and my programs who guided me and supported me through this journey. I would not have made it without them 😊

NIAMS

@NIH_NIAMS

2 years

Congratulations to Mariana Correia Marques, MD, a recipient of the 2023 ACR Distinguished Fellow Award! Mariana is a clinical fellow in the NIAMS Translational Genetics and Genomics Section and studies systemic juvenile idiopathic arthritis. #ACR23

19

7

115

Grant Schulert, MD PhD

@GrantSchulert

2 months

Michael Matt, newest member of our @CincyChildrens faculty, presented his work with the @carrainc FROST study, part of a collaboration with our friends @MichaelOmbrello and @MCMarquesMD

1

2

6

George Robinson

@GeorgeARobinson

9 months

Today is #WORDDay2025! An incredibly important cause to raise awareness of young rheumatic diseases and improve research, care, and support for patients. Please spread the WORD and and follow @WORDDay_org to find out more 👇

World Young Rheumatic Diseases Day (WORD Day)

@WORDDay_org

9 months

Today’s the day! Join us for our exciting webinar later today as we celebrate WORD Day 2025! 📅 Today - Tuesday 18 March 2025 | 7 PM CET It's not too late to register! ⬇️ 🔗 Register for free: https://t.co/b1GPRaYOmj Let’s make a difference together! 🌍💙 #WORDDay2025

0

4

7

NIAMS

@NIH_NIAMS

9 months

Dr. Mariana Correia Marques, a NIAMS Intramural researcher focusing on juvenile idiopathic arthritis, was recently highlighted by the Childhood Arthritis and Rheumatology Research Alliance (@carrainc). Read their spotlight: https://t.co/APGFXljXy4 @MCMarquesMD @IRPatNIH

1

2

11

Mariana Marques, MD

@MCMarquesMD

11 months

Very honored to have been selected as the member spotlight for @carrainc this month. This organization played a very important role in my training, and gave me great opportunities. I’m very glad to be an active part of it 😊 https://t.co/2uPFli0gUf

carragroup.org

Dr. Mariana Correia Marques, located in Bethesda, MD, is a physician-researcher at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NI

2

20

CannaLab

@canna_lab

11 months

AlloHSCT for refractory sJIA-LD. Congrats @GrantSchulert, Rebecca, ... and @sjiafoundation - whose session at a NextGen a few years ago made it clear how much this was needed. https://t.co/rzOsS34eQy

thelancet.com

Allogeneic HSCT might be a valuable treatment option for patients with refractory sJIA and sJIA-LD and should be considered for children with worsening oxygen dependence or severe treatment-related...

0

1

10

seza

@drsezaozen

1 year

https://t.co/DFRY3KV4Da

0

15

33

seza

@drsezaozen

1 year

PReS is launching the “PReS Introductory Course on Pediatric Rheumatology”, a new educational initiative.This programme will be a 2-year webinar series, featuring monthly aligned with the PReS syllabus. The recordings will be available (for free!) for PReS members

1

9

27

Mariana Marques, MD

@MCMarquesMD

1 year

#ACR24 is officially over, but we still have so much to catch up on content! (Somehow it feels like the sessions you want to watch are all at the same time). Very thankful for the recorded videos 🙏🏼 #ACRAmbassador

American College of Rheumatology

@ACRheum

1 year

LISTEN in as Dr. Kaser explains his thoughts on new therapies being developed for macrophage activation syndrome → https://t.co/esXEZFS4jE #ACR24 @ACR_Journals

1

3

16

Mariana Marques, MD

@MCMarquesMD

1 year

#ACR24

0

Mariana Marques, MD

@MCMarquesMD

1 year

Very interesting results from the emapalumab trial in #MAS and #Stills Interesting that LDH seems to be less specific for MAS given new emerging complications!

1

8

34

Eduardo Martín-Nares

@drlalonares

1 year

👉🏼 @Amansharmapgi presenting a DADA2 Cohort of 101 Patients from 🇮🇳 Take home messages: 🔸”DADA2 is no longer a disease of the children” 🔸Mesenteric ischemia, stroke and non-usage of anti-TNF are predictors of mortality #DADA2 #ACR24 #ACR2024 #vasculitis

1

20

36

Mariana Marques, MD

@MCMarquesMD

1 year

And you can always phone a friend! We genomics people are a bunch of nerds who love to talk about it. I’m always happy to chat with anyone who has some weird genetic question 😊

0

2

Mariana Marques, MD

@MCMarquesMD

1 year

And what to do with VUS? Keep calm and Google it! Great resources to look at! #ACR24

1

4

5

Mariana Marques, MD

@MCMarquesMD

1 year

For those patient, it’s worth it to go with broad sequencing first. Overlapping presentations make it hard to choose the right functional test. #ACR24

1

3

6

Mariana Marques, MD

@MCMarquesMD

1 year

Awesome session on how to interpret genetic sequencing for patients suspected of inborn errors of immunity. Here are some hints suggestive of a genetic immune disease #ACR24

1

8

20

Mariana Marques, MD

@MCMarquesMD

1 year

Congratulations @DidemSayginMD and Dr Kaveh Ardalan! Both amazing people who were extremely deserving! ❤️⭐️

Didem Saygin, MD

@DidemSayginMD

1 year

Thank you for the highlight and glad to finally meet in person with #RheumChampion @realcc #ACR24 @RheumResearch

1

0

11

Rheum Cat

@rheum_cat

1 year

Congrats to 💫 @DidemSayginMD!! #ACR24

Didem Saygin, MD

@DidemSayginMD

1 year

Thank you for the highlight and glad to finally meet in person with #RheumChampion @realcc #ACR24 @RheumResearch

2

17

Mariana Marques, MD

@MCMarquesMD

1 year

It is a true mission impossible to get consensus on what to do in sJIA lung disease. Unfortunately I couldn’t get the picture of the first question, but it was an event split 4 ways. =X